Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
3Y CAGR-14.5%
5Y CAGR+22.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-14.5%/yr
vs +128.9%/yr prior
5Y CAGR
+22.5%/yr
Recent deceleration
Acceleration
-143.4pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.07M | -59.6% |
| 2024 | $12.54M | +20.1% |
| 2023 | $10.44M | +28.9% |
| 2022 | $8.10M | +297.0% |
| 2021 | $2.04M | +11.3% |
| 2020 | $1.83M | +240.3% |
| 2019 | $539000.00 | +82.7% |
| 2018 | $295000.00 | - |